Curiox Biosystems, a bio-instrumentation company backed by Singapore-based venture investment firm Zig Ventures, has raised $15 million in its Series B funding round that it will use for global commercialisation activities.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
